Upcoming Events

The 6th Airfreight Pharma Conference takes place in Brussels, one of the centre points of the airfreight pharma community and is an opportunity for the supply chain to enhance their understanding of the handling of pharma products.

CCA events are designed to bring the industry together to share and innovate in creating a seamless chain for the handling of pharma products.

At the conference, delegates can enjoy lively, open and honest debates on challenges faced within the pharma sector with a focus on greater collaboration, cooperation and communication between CCA members and stakeholders of the industry.

Pharmaceutical companies are legally and ethically obligated to make available the most up to date information on how to use their products safely on the label for healthcare professionals and patients. Because the regulatory requirements, labeling is a very critical component of a product registration dossier. Once approved, it serves as the document that tells a complete story about the product. Labeling provides compressive information on a product and determines the proper treatment for the patient. Packaging plays a huge role in keeping the drug and device from contamination safe for its patients and users.

Labeling is not only one of the most complex, cross-functional processes within the pharmaceutical industry. It is one of the most common areas of inspection findings and it is critical to have an end-to-end labeling to packaging process to ensure patient safety. This year, the 2nd Safety Labeling and Packaging Summit will explore best practices to develop and enhance an end-to-end process to ensure a compliant label for your drug packaging.

The cosmetics industry faces complicated, novel challenges and concerns. Extensive regulation is stifling creativity and social media is furthering brand-damaging propaganda. Strategies to address these new-age issues are desperately needed as corporations chase the next, new trend while also supporting compliance throughout the supply chain. In a market dictated by the consumer, balance between innovation and compliance is your key to success in chasing those trends.

Join us for an overhaul of our past programs as we take on a more global view focused on every step of the process leading to cosmetic compliance, from R&D to finished product.

7th International Conference on Clinical Trials is scheduled to be held during September 24-26, 2018 at Chicago, USA. This Clinical Trials Conference includes a wide range of Keynote presentations, Plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs

Conference series LLC Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series LLC Ltd website will provide you list and details about the conferences organize worldwide.

ConferenceSeries LLC Ltd proudly announces the commencement of its “12th World Drug Delivery Summit” which is going to be held during September 24-26, 2018 at Chicago, USA. The conference highlights the theme “Advanced techniques for safer and efficacious drug delivery”. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics Drug delivery, Novel Approaches on Product Development, Biopharmaceutics, vaccine drug delivery, Pharmaceutical Innovation in the 21st Century, New scientific approaches to international regulatory standards. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Healthcare professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Drug Delivery International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements. Drug Delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. The sessions of this conference are more concerned with drug delivery technology, novel drug delivery systems, novel routes of administration, pharmaceutical nanotechnology, nucleic acid-based drug delivery, smart drug delivery, vaccine design and delivery technology, drug delivery companies and markets, biopharmaceutics  as novel technique in drug delivery, drug devices and device development, peptide and protein drug delivery, drug delivery equipment’s and machinery and major challenges in drug delivery and Pharmaceutical companies.   

Performances of intelligent drug delivery systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. This summit describes the advanced drug delivery systems based on sustain drug delivery, targeted drug delivery system, controlled drug delivery, ocular drug delivery, transdermal drug delivery, transmucosal drug delivery through novel routes as Intranasal, parenteral routes, buccal routes, tropical routes with pharmacology aspects. Pharmaceutical nanotechnology embraces applications of nanoscience to the pharmacy as polymeric nanoparticles, Liposomes, dendrimers, nanomedicine, nanoemulsion for drug delivery.

Middle East Pharmacy and Pharmaceutical Conference scheduled on September 24-25, 2018 Abu Dhabi , UAE. Conference includes Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from top Universities, Formulation Scientists, Researchers, Health care professionals, Pharmaceutical companies, students, business delegates and Young researchers, Health care professionals, Business delegates across the globe providing a better platform, interconnecting the latest research, technological developments as well as therapeutic aspects. Participating at Middle East Pharmacy and Pharmaceutical Conference will be good opportunity to meet eminent personalities in the fields of pharmaceutics and to learn the latest technological advancements.

At the 16th Annual Cold Chain Global Forum, we will gather the top pharma supply chain executives and suppliers to address end-to-end supply chain optimization, create strategies to maintain temperature controlled products, remain complaint with regulatory agencies, and implement customer centricity to enhance patient first initiatives. Join us this September, for strategic content by cold chain professionals for cold chain professionals

Event Agenda: http://bit.ly/2v7SxI8

Registration: http://bit.ly/2qouGhR

Homepage: http://bit.ly/2uZ2urn

Email enquiry@iqpc.com

Phone Number: 1-800-882-8684

Medical affairs teams are involved in nearly all aspects of communication in a pharmaceutical/biotechnology/medical device organization. Their scope and authority can vary depending on the size of the business. One of the biggest issues medical affairs teams have faced in recent years has been the need to establish standard operating procedures and quality control measures for social media posts. With Twitter, Facebook and other networks in use by virtually all employees, medical affairs teams need to pinpoint who regulates company posts, what information is released and how posts should be edited.

This track will address the management and communication concerns internal teams face as well as how to best improve current processes in order to comply with new regulations and the instant access to information.

As the technological market speeds ahead, many challenges directly impact innovation leaders. Capitalising on external innovation and strategic partnerships is crucial to gain and maintain a competitive advantage. ENG’s 8th annual summit will bring leading innovation, techscout and corporate venture executives together from an array of top companies across different industries to discuss the future of innovation and new approaches to drive business. Join us in Madrid for two days of strategic insights, an interactive panel discussion, dynamic case studies and a workshop. This event will provide you with the strategic insight on how to drive disruptive businesses and increase profit through effective scouting and partnerships.

RWE is at the root of a critical transformation in the way we are looking at clinical development, drug life cycle and commercialization activities

Today more than ever, real-world data collected from mobile, digital and AI technologies are used to help drug developers in generating more value-based outcomes in the development and accessibility of new treatments.

To gain competitive advantage and achieve better outcomes, pharma and biotech organizations seek to advance the way they use RWE - real-world evidence, for the benefit of patients and the commercial success of their products.

The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) is a federation composed of 63 official national associations of bariatric surgeons and individual members.

IFSO's Mission is to Unify the Global Scientific, Surgical and Integrated Health Communities, for the Purpose of Dissemination of Knowledge, Collaboration and Establishing Universal Standards of Care for the Treatment of Individuals with Adiposity-Based Chronic Disease.

The main goal of IFSO is the optimisation of the treatment of severely obese patients bringing together surgeons and allied health professionals. IFSO is committed to the creation of a global system for accreditation of bariatric centres and individual surgeons.

IFSO's main activity is the organization of the yearly World Congress, which provides a forum to exchange knowledge on surgical treatment of severely obese patients, to present new techniques, research and concepts, and to meet the experts in the field.

Conference Series LLC Ltd cordially invite all the participants from all over the world to share their latest research in the field of Clinical Pharmacy at 5th International Conference on Clinical Pharmacy and Health Care which is going to be held on September 26-27, 2018, San Antonio, Texas, USA. This Clinical Pharmacy Conference includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs.

Clinical Pharmacy Conference aims to bring together prominent educational experts, researchers and research specialists to exchange and share their experiences about all segments of Clinical Pharmacy. It also provides the disciplinary aid for researchers, experts and mentors to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the results implemented in the field of Clinical Pharmacy. All commendable authors are kindly encouraged to contribute and help to shape the conference through submissions of their research abstracts, papers and e-posters. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including references of novel research material. In the light of this theme, the conference series aims to provide an aid for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest innovative research findings and results about all features of Clinical Pharmacy.

For 10+ Years Running, the Pharma CI Conference and Exhibition Is the Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives in the World!

Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the competitive intelligence community today. This is the only event featuring a world-class line up of speakers and panelists offering their unique insights and expertise on the topics you care about most!

The Pharma CI Conference & Exhibition is THE INDUSTRY’S GOLD STANDARD for senior level pharma, biotech, and device professionals seeking the latest news and the rare chance to network with all the industry’s luminaries. If you’re interested in where your company is headed this year and beyond, you can’t miss this big event of the year!

The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK.

Following the success of our previous events in both UK and USA, Biosimilars and Biobetters UK 2018 will deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.

After over a decade, the biosimilars industry is finally reaching a stage where key stakeholders understand and accept biosimilars. This is reflected in more tolerant legislation and an increased uptake of biosimilars across the globe.

SMi is proud to present the inaugural Immuno-Oncology Conference, taking place in London on the 26th-27th of September, 2018.

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.

This event will draw together different, key facets of the rapidly evolving field to propagate invigorating and thought-provoking discussions between industry leaders and inform and update delegates on current key areas for development, on future potential therapies advancements and provide revisions of regulations.

The Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

Annual Pharma Pricing & Marketing Congress will be held on 26-27 September 2018 at Dubai UAE. The main theme of the conference is ''Understanding the Drug Costs, Drug Pricing and Pharmacoeconomics''

Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events.The key strategic objective of Meetings Int. is to communicate science and medical research between academia, and industry. We organize conferences world-wide. All major conferences of Meetings International are accredited with Continuing Professional Development (CPD), Continuing Education (CE), and Continuing Medical Education (CME) Credits.

With the US in the midst of an opioid crisis, it has never been more critical for the pharmaceutical, biotechnology and academic fields to unite in a common goal to innovate and accelerate the discovery and development of novel non-opioid therapies to treat pain.

This summit and its expert speaker faculty will update you on the latest and novel R&D efforts currently ongoing in discovery and optimization of non-opioid analgesic targets and their mechanism of action. In addition, the inaugural Non-Opioid Pain Drug Development Summit will be your dedicated platform to overcome translational challenges such as animal model predictive value, biomarker identification, and proving efficacy against placebo effect. So join our platform to understand the science and also critical decision making processes that are crucial to successful non-opioid pain drug development.

11th World Congress on Pharmaceutical Sciences is scheduled to be held during September 28-29, 2018 at Montreal, Canada. This Pharmaceutical Sciences Conference includes a wide range of Keynote presentations, Plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs.

Conference series LLC Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series LLC Ltd website will provide you list and details about the conferences organize worldwide.

THE Authoritative MDRP Event on Government Pricing, Rebates, and Regulation

Unparalleled access to government officials creating regulatory rules, the industry leaders interpreting them, and the pharma executives implementing them.

Conference Series Ltd  is overwhelmed to announce the commencement of “12th International Conference on Endocrinology , Diabetes and Metabolism” to be held during October 01-02, 2018 in Osaka, Japan. The upcoming conference will be organized around the theme " Bridging excellence in Endocrinology, Diabetes & Metabolism".

Conference Series Ltd invites Endocrinology & Diabetes expertise, researchers, professors, scientific communities, therapists, counselors, delegates, students, business professionals and executives to attend 12thInternational Conference on Endocrinology , Diabetes and Metabolism Summit which is going to be held on October 15-17, 2018 at Osaka, Japan. Conference Series Ltd organizes 1000+ Global events inclusive of 300+ Conferences every  Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.      

Enhance the Translation & Clinical Validation of Novel Predictive Biomarkers & Maximize the Commercialization of Diagnostic-Enabled Precision Medicines

The 9th Clinical Biomarkers & World CDx Boston 2018 summit is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.

As the place to be for the precision medicine field, Clinical Biomarkers & World CDx Boston covers end-to-end the development, clinical implementation and commercialisation of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from R&D to providing patients with the right treatment decision and most effective therapies at the right time.

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd-3rd, 2018 in Vienna, Austria.

This premier B2B event provides you with an appropriate platform to engage with and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for excellent company representation and development.

The Summit will shed light on current challenges, best practices, and inside views of the future of Microbiome in relation to precision medicine.

We will discuss key findings, critical insights, and recommendations for driving efficient strategies within the Microbiome landscape.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna in October!

With compliance stakes rising, internal audit departments are far more prominent and hold more responsibility than ever before. CBI’s Internal Audit Summit is the bio/pharmaceutical and medical device industry’s most in-depth forum driven by industry to equip the IA community with proven strategies to conduct thorough and detailed audits of high-risk areas enterprise-wide.

This highly-focused, content-rich program paves the way to navigate the latest industry trends and compliance hurdles facing IA teams in an ever-changing, complex and rigorous reporting environment.

We are pleased to invite you to the Immuno-Oncology Summit, scheduled for October 3rd -4th, 2018, in Vienna, Austria.

This Summit is focused on Immuno-Oncology this rapidly evolving field and the most promising new cancer treatment approach since the development of the first chemotherapies.

It will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Immuno-Oncology, and discuss the latest advancements and improvements in research and development, business opportunities in partnering and investing. We will discuss key findings, critical insights, as well as recommendations for accelerating development in the field.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna, this coming October!

The 8th annual EPP Life Sciences Pricing Forum has become the “must” go event for Pricing and Market Access senior executives and innovators, who want to learn and discuss the trends and developments in the pricing and profit optimisation area.

This year’s forum is completely re-designed to cover the most up to date pricing and market access real-world insights, trends and real case studies with information not available in any other event.

International Pharmaceutical Academy (IPA) is delighted to be hosting its 14th annual GMP Update | BPF Mise à jour 2018 on October 3-4, 2018 in the historical city of Montreal, Canada. The conference will provide attendees with insight and a plethora of information on quality, compliance, validation, and regulatory areas affecting the pharmaceutical, biopharmaceutical and allied industries. It will address compelling issues and the current challenges of GMPs in a global marketplace.

The “GMP UPDATE 2018” is the place to be for an unparalleled learning experience and networking opportunities.

We are pleased to invite you to the 4th Annual Biomarkers - CDx - Precision Immunotherapy Summit scheduled for October 4th - 5th, 2018 in Vienna, Austria.

This premier B2B event provides the appropriate platform for participants to engage with and discuss ideas with their fellow peers, while facilitating a professional atmosphere and environment for excellent company representation and development.

The Summit will shed light on current challenges, best practices, and the inside view of the future of precision diagnostics & immunotherapy. We will discuss key findings, critical insights, and recommendations for driving efficient strategies in the diagnostics & immunotherapy landscape.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna in coming October!

The only event that is pulling out all the stops to help you

The next edition of The Pharmacy Show will be taking place on Sunday the 7th and Monday 8th of October 2018 at The NEC in Birmingham.

Funding cuts, staffing levels reduction, increased demand for primary care settings… The past few years have been challenging. With revalidation, GDPR and FMD, 2018 brings further changes that need to be implemented for 2019.

Join pharmacy experts and key opinion leaders, new and existing suppliers and policy makers to keep up with all latest developments, grow your business, improve patient outcomes and get all the practical training and advice you need.

Plus, get the bulk of what you need for revalidation with plenty of planned and unplanned learning activities as well as networking opportunities for peer-to-peer discussions.

ConferenceSeries Ltd invites the contributors across the globe to participate in the premier “18th International Conference on Nanomedicine and Nanotechnology in Health Care” (Nanomedicine 2018) (CPD Accredited), to discuss the theme: "Embarking Next Generation Delivery Vehicles for Affordable Healthcare.” The conference will be held at Osaka, Japan during October 08-09, 2018.

Conference Series Llc organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members

18th International Conference on Nanomedicine and Nanotechnology in Health Care (Nanomedicine 2018) (CPD Accredited) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Nanomedicine in Healthcare. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Nanomedicine. The conference program will cover a wide variety of topics relevant to the Nanomedicine, including: Nanomedicine in drug discover and delivery, Nano diagnostics, theranostics, applications of Nanomedicine in healthcare applications and disease treatments.

ME Conference  invites all the participants from all over the world to attend “Cancer Genomics Conference: New Era for Cancer Prevention” which is to be held in Dubai, UAE on 25th – 26th June. This includes a well organized scientific event consisting workshops, symposiums, exhibitions of oncological instruments, new diagnostic therapies and special sessions for young researchers and students with modern and advance research from top universities, research centers, hospitals.

The unique international on Cancer Genomics Conference: New Era for Cancer Prevention 2018 directs towards addressing main issues as well as future strategies of cancer. This is going to be the largest and most promising international conference where the researcher as well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of cancers. The program includes the complete information of cancers including cancer target therapy, Cancer nursing and care, Economic impact on cancer, Biomarker and  advance use of biomarkers, the entire medical team involved in patient care ,researcher, Professional, early career individuals and patient advocates who wish to learn principles of tumor immunology and immunotherapy.

Oxford Global Conferences are proud to present our Industrial Synthetic Biology Congress taking place on the 8th & 9th October 2018 in Munich, Germany. Join over 150 senior level attendees from leading life sciences companies and research institutions to discuss the latest applications of synthetic biology for the chemical and pharmaceutical industries.

Synthetic biology is revolutionising biomanufacturing, but thorny challenges remain. Now is the time for experts in the field to develop and improve techniques for stabilising production processes and for increasing yields to commercially viable levels.

Our panel of 36 senior professionals will discuss the latest methodologies and the best strategies for applied synthetic biology for industrial purposes. From metabolic engineering and pathway design to advances in heterologous expression and screening technologies, these talks will cover the critical technologies in the field.

INCREASE PRODUCTIVITY AND QUALITY to accelerate your biologics and novel molecules towards commercial success

Apply practical case studies from global mammalian and microbial experts working across upstream, downstream and manufacturing facility design

The global OCT series extends to Switzerland in 2018 to bring innovative and solutions-focused content to the DACH biopharmaceutical market.  Spinning off from the flagship OCT Europe event, this intimate audience of local players allows for focused, lucrative learning and networking on site.

Through in depth research conducted with local biopharma companies, this event will deliver insight, debate, discussion, presentation and opinion on high priority outsourcing, operations and technology based themes within the clinical trial space locally.

As a high-income country with increasingly tightening pricing constraints, Australia is a unique market for pharma. Access has become critical for every function, and commercial leaders need new tactics and knowledge to adjust to the changing timelines.

The opportunity is there, and international pharma HQs can’t afford to ignore the region, but they desperately need a new, leaner commercial model to succeed.

Embrace a smarter use of digital methods, create better internal working models that hit launch timelines, have a more customer-responsive field force and produce a better roadmap for market access at this years eyeforpharma Sydney 2018.

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 45,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars.

Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.

This year, we’re taking the crème de la crème of the pharmaceutical industry to the lively city of Madrid where 2018’s event will take place at IFEMA, Feria de Madrid from 9-11 October.

Anyone who is looking for an overview of the entire pharmacy market simply has to come to expopharm: Here, important manufacturers show their new products, visitors experience the latest programmes of the large software houses and pharmacists find the services which make their work in the pharmacy even more efficient.

Expopharm is the home of the pharmacy market – and for over 50 years, the undisputed number 1.

As cancer care costs steadily rise, innovations in oncology care management and payer-provider payment reform remain a critical imperative for key stakeholders. Now in its 13th year, CBI’s Value-Based Oncology Management convenes payers, providers, PBMs, manufacturers and specialty pharmacies to examine current challenges and share best practices to control costs, reduce variation in care and improve patient outcomes.

Oxford Global is proud to present the 5th Annual Drug Discovery USA Congress taking place on the 11-12 October in San Diego 2018.

The conference will feature over 30 presentations from leading heads of the pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate. Topic discussion ranges across a variety innovation and strategies in drug discovery such as new modalities for challenging targets and discovery models in microbiome, neuroscience and cardiovascular.

Further talks look at the approaches to phenotypic and genomic strategies in drug discovery and novel approaches to drug design such as protein-protein interactions, structure-based drug design and hit identification technology in DNA Encoded Library. Furthermore, discussions on the latest topics in computational chemistry and informatics for drug discovery will also be a key highlight at the congress.

Key Speakers include Vice Presidents, Directors and Executives from leading pharmaceutical and biotech industries such as Pfizer, Merck and Sanofi. The two-day congress offers the opportunity to have scientific and business discussions, ensuring valuable networking and interactive sessions while bringing together 350 senior industry experts.

View the Agenda here>> https://bit.ly/2jrExDf

Join over 350 delegates from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Over 20 presentations, case studies and panel discussions focusing on the latest innovations in Car-T cell development, patient stratification and assay developments in the immuno-oncology world.

2 Interactive Streams:

    Development of Immuno-Oncology Therapies – Stream 1 features presentations on the latest developments in T Cell Engagers, cell based functional assays for IDO inhibitors, harnessing novel immune escape mechanisms for cancer therapeutics and toxicities with immuno-oncology therapy
    Translational Immuno-Oncology and Clinical Development – Stream 2 addresses talks on the latest patient stratification innovations in immuno-oncology, identifying immunological biomarkers for precision cancer immunotherapy and Biomarker based selections in clinical trials.

7th International Conference and Exhibition on Pain Research and Management’’ that is going to be held on October 11-12, 2018 in Zurich, Switzerland.

The purpose of 2 days conference is to bring together attendees from around the world who are interested in exploring the link between pain and its management. The conference will focus on topics such as Pain management & rehabilitation, Anesthesiology and Pain medicine, Physical & physiological approaches in pain management, Pain relief analgesics, Interventional pain management, Cancer pain management, Novel therapeutic approaches for pain management and much more. Altogether, the conference will feature presentations on the newest developments in pain management and research.

As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance.

Whether you are a community pharmacist or a hospital pharmacist, the 5th Annual GCC Pharmacy Congress is the ideal platform for you as it gives you the opportunity to select your track according to your job profile. The congress has two tracks; one for hospital pharmacy and another one for community. Both tracks will help you in developing your leadership skills, giving you the required exposure to the new technologies and advances in your field and helping you to improve the quality of care delivered to the patients.

The mission of the 5th Clinical Trials Phase I & Phase IIA Summit is to provide attendees with the strategies and insight necessary to ensure their early stage clinical trials are executed on time and within budget while exploring how to leverage innovative approaches to managing clinical trials for all therapeutic areas.

The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. All the major players in the pharmaceutical industry are very well-represented. However, we also take great measures to make sure this conference remains intimate and exclusive. For example, the limited exhibitor spots are available to only premier providers. This helps ensure a high-quality and productive event for everyone attending.

This conference happens only once a year, so be sure to take advantage of this amazing opportunity!

India’s Leading Trade Fair for Water, Sewage, Solid Waste and Recycling will again open its doors from October, 15-17, 2018 at Bombay Exhibition Centre in Mumbai. IFAT India is an ideal platform to network with industry leaders and business partners from across the globe.

In the background of mounting and persistent pollution problems will see a steady growth in India’s fragmented environmental technologies market. Along with the increased market demand and inputs by the government, the business potential in the environmental industry in India will be huge. Undoubtedly, IFAT India 2018 will be a foremost choice for the environmental sector stakeholders to come together, exchange ideas and seek solutions.

IFAT India 2017, which was held in the Bombay Exhibition Centre (BEC), Mumbai, from September 26-28, received an overwhelming response, once again reaffirming that it’s a leading environmental technology show in India. The fifth edition witnessed 6765 visitors, this marks a 30 percent increase compared to the previous year. This year also saw an increase in exhibitors and floor space: 184 exhibitors represent a rise of 29 percent and 33 percent more floor space, 8100 square meters.

This summit continues to grow in popularity and renown among discerning TMF professionals. Pioneering and illustrious leaders of the 7th European TMF Summit constitute a high calibre speaking faculty who are eager to share their insights and experiences.

The synergy of each year’s cohort amplifies the compelling and meaningful content that this event is known for. The rich discourse and participatory character of the case studies, interactive workshops, panels and expository sessions ensure that you will to return to work prepared, equipped and confident your ability to realize continuous improvement;

The quality and immediate relevance of topics are assured every year by the certainty that this event is by and for TMF professionals. And through the addition of a second track, participants may customise their own learning and networking experience.

The ACF is a cost-effective way to network and showcase your business to thousands of leaders and buyers from across the entire air cargo supply chain. ACF is the perfect opportunity to promote and launch new products and services and to interact with potential and existing customers, partners and suppliers.

    Provides a unique platform for the exchange of ideas, views and solutions to the many issues which our industry faces on a daily basis
    Panels and workshops designed to educate & promote solution minded discussions as well as deliberating over future industry trends
    Ideal for anyone looking to increase productivity or boost efficiency
    Promotes ‘face to face’ interaction assuring that attendees leave with more than just a brochure… A positive experience is by far the best method of attaining consumer's interest
    A great opportunity to build relationships with potential vendors and buyers

After all, true patient centricity means going beyond the needs of your company and working with stakeholders to harness the greatest value possible.

For 15 years, the Patient Summit has championed engagement and advocacy. Now we go back to our roots as the definitive platform to bring together patients and industry in an environment that fosters natural co-creation and insight.

Digital Pharma East is the leading marketing conference globally for life science professionals looking to learn, network and be inspired.

The industry’s “go-to” event for innovative and emerging bio/pharmaceutical and medical device manufacturers ramps up for the most in-depth and impactful year yet. Backed by 9 years of high-quality content, this congress continues to elevate the bar in compliance by convening the brightest minds and most influential stakeholders to converse on the unique compliance challenges and risks, from pre launch to commercial, within life sciences.

SMi's 8th Annual Orphan Drugs and Rare Diseases Conference returning to London in October 2018.

This year’s SMi will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing.

Reserve your seat early and Save £500 - available only by 31 May!

Despite the recent growth in the orphan drug market, the processes leading to the approval of orphan drugs is still complex and includes many challenges to overcome, such as regulations and sustainability. With the global Orphan Drug market expected to grow to $169 billion by 2020 there is a constantly growing awareness and interest for this industry, enabling more research to make a difference in patients’ lives. SMi’s Orphan Drugs and Rare Diseases conference will once again bring together some of the leading senior industry professionals to network, learn, and discuss current issues in the rare disease industry.

ME Conferences merrily welcomes you to attend” International conference on Pharmacology and Toxicology” during October 18-19, 2018, at Dubai, UAE with a theme of Broaden the possibilities of pharmacology and toxicology. ME conferences is an Open Access Initiative is committed to make genuine and reliable contributions to the scientific community.

On behalf of organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Pharmacology and Toxicology. World Pharmacology 2018 conference is scheduled during October 18-19, 2018, at Dubai, UAE. This conference aim is to gather the most elegant societies and industries along with the renowned and honourable persons from top universities across the globe. The World Pharmacology 2018 organizing committee is confident that participants will get benefits from this high value scientific program. We welcome all the researchers/ academicians join us at Dubai, UAE.

Pharmacology is integrative of fields like biochemistry, toxicology, genetic engineering, molecular engineering and its advancement using nanotechnology. Pharma includes health care contribution to drug development and discussed about research and innovative works in the pharmacy field. During this conference, the international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of pharmacology and toxicology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques. In all its ways World Pharmacology 2018 creates an opportunity to make partnership deals which will turn into a cent per cent success meet.

Pharma Medicinal Chemistry 2018 invites all the participants from all over the world to attend the 18th International Conference on Medicinal and Pharmaceutical Chemistry  which is going to be held during October 18-19, 2018 in Dubai, UAE. The main theme of the conference is “Explore the future of Medicinal and Pharmaceutical Science”. This Conference helps in meeting of professionals, experts, academicians and researchers from all over the world.

Conference Series is delighted to invite you to attend the 4th International Conference on Drug Discovery and Advanced Drug Delivery Systems & Technologies, one of its remarkable Pharmaceutical conferences, to be held during October 18-19, 2018 in Warsaw, Poland emphasizing on recent areas of more optimized research techniques like rational and computer aided drug designing for the Discovery, Designing and Development of new drugs than by traditional hit and trial method. This Drug Discovery Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

Conference Series Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conferences organize worldwide.

ConferenceSeries invites all the participants across the globe to attend 18th World Pharma Congress during October 18-19, 2018 Warsaw, Poland. Which includes keynote presentations, plenary sessions, poster presentations and exhibitions? Pharma Congress 2018 is specially designed cluster Pharma conference. The main theme Pharma congress is “ Challenges and Opportunities in Transforming the Pharma Industry” that emphasizes Impact of developing and Marketing Drugs, its registration & approval” which covers a wide range of critically important sessions.

The 34th World Congress of Internal Medicine for 2018 will be held in the beautiful city of Cape Town in South Africa, at the International Convention Centre from 18 to 21 October 2018. All aspects of Internal Medicine will be covered during parallel sessions presented by an exciting faculty drawn from experts across the international community. The aim of the meeting is to provide an excellent academic programme for the general physician but of a standard that the specialty groups such as Rheumatologists, Cardiologists, Pulmonologists and so on would also benefit.

ME Conferences merrily welcomes you to attend” International conference on Pharmacology and Toxicology” during October 18-19, 2018, at Dubai, UAE with a theme of Broaden the possibilities of pharmacology and toxicology. ME conferences is an Open Access Initiative is committed to make genuine and reliable contributions to the scientific community.

On behalf of organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Pharmacology and Toxicology. World Pharmacology 2018 conference is scheduled during October 18-19, 2018, at Dubai, UAE. This conference aim is to gather the most elegant societies and industries along with the renowned and honourable persons from top universities across the globe. The World Pharmacology 2018 organizing committee is confident that participants will get benefits from this high value scientific program. We welcome all the researchers/ academicians join us at Dubai, UAE.

Convening validation professionals of all levels for unmatched training, IVT’s 24th Annual Validation Week provides a transformative exploration through the world of validation. Build your own conference adventure and trek your way between four unique tracks — Process Validation, Quality, CSV/Data Integrity and Cleaning Validation. Navigate the critical aspects of validation with subject matter expert trailblazers and uncover a wide range of solutions to your organization’s specific challenges.

Back by popular demand and rave reviews, IVT will host the 2nd Annual Women in Validation Empowerment Summit featuring a diverse panel of accomplished women in the validation and engineering field to lead an inspiring and constructive conversation where participants can share practical techniques for optimizing performance both personally and professionally.

Join manufacturing leaders from across the Americas and beyond to discuss, share and learn about...

    How to achieve faster, more agile, flexible and responsive production
    Engaging, developing and recruiting your workforce to avoid a skills gap
    Cost reduction methods
    Implementing new technologies and increasing cyber security
    Lean & OpEx strategies to streamline your processes
    How to implement the same lean & OpEx strategies across multiple plants
    Digital Manufacturing & The Internet of Things for whatever stage you’re at

Gene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.

Rather than early stage basic science, this meeting is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward.

Precision CRISPR Congress supports pharma and biotech community in realising the drug discovery & gene therapy applications of optimised CRISPR systems

The 2nd NASH Summit Europe fills the gap as the only industry-led forum dedicated to harnessing the NASH biopharmaceutical understanding and focusing on the most pressing drug development challenges with a tighter lens, including:
 

• •  The potential for stand-alone versus combination therapeutics
• •  The genetic drivers influencing disease heterogeneity
• •  The future payer and reimbursement landscape

Built from research with 20 NASH stakeholders including the FDA, EMA and Gilead; the 2nd NASH Summit Europe brings together the leading experts in the only forum dedicated exclusively to collaborative discussion and networking for NASH drug developers.

The Industry’s Leading 100% Interactive Forum for Establishing Best Practice in Early and Managed Access Programmes. Discover Strategies for Launching and Managing your Programme, Navigating the Complex Regulatory Landscape and Get to Grips with the Patient’s Perspective!

‘Managed Access’, ‘Early Access’, ‘Compassionate Use’, ‘Expanded Access…. –  there may be many names but there’s one goal – to provide critical access to medicines and devices for the treatment of a patients with rare and debilitating diseases.

The Early and Managed Access Programmes Forum - The world's first and most prestigious EMAP event - returns in October 2018, where industry leaders from Janssen, Novartis, Alexion and Bionical will discuss their EMAP strategies with solicited input from Patient Advocacy Groups and Regulatory Professionals from across Europe and the US.

Are you currently running an Early or Managed Access Programme? Are you looking to launch, optimise or achieve operational excellence but are unsure of the next steps in your strategy? We all know that the demand is growing but Pharma is yet to take up global action , which is why this year’s  forum will ensure that you are able to implement the best strategy possible.

As the perfect environment to engage with Industry experts who have launched, managed and transitioned out of EMAPs, this year’s event will see 20+ industry expert speakers ready to help your team feel confident in addressing the management, operational and collaboration aspects of your EMAPs and ensure you feel secure in your next steps.

Join Oxford Global at the 4th Annual NGS & Clinical Diagnostics USA Congress 2018 to discuss the future of sequencing with key innovators from Pharma, Healthcare and Academia! Featuring over 50 presentations and case studies looking at emerging trends in NGS data analysis, clinical diagnostics and biomarker development as well as novel therapeutic applications, this congress will bring together over 200 senior level attendees.

Pharma – Learn more about NGS in pharmaceutical research and development! Critical case studies and presentations on: whole genome se quencing applications; NGS in clinical trials and NGS in biomarker development.

Healthcare – NGS is revolutionising healthcare, allowing clinicians to take a more personalised approach to care. New for 2018 the congress will be looking at NGS and metagenomics, improved next generation sequencing techniques in liquid biopsy as well NGS in precision medicine.

Academic – Hear about the latest research in the field looking at new technologies and techniques. Critical areas include advances in NGS data analysis, long read vs. short read sequencing and novel therapeutic applications.

Join Oxford Global at the 4th Annual Single Cell Analysis USA Congress 2018 to discuss the future of this rapidly evolving field with key innovators from Pharma, Healthcare and Academia! Featuring over 25+ presentations and case studies looking at single cell omics analysis, therapeutic and diagnostic applications as well as critical single cell analysis challenges this congress will bring together over 200 senior level attendees.

Our 3 interactive streams will Cover: 

•    Single Cell ‘Omics Analysis: Current and Emerging Tools
•    Translation to Diagnostic and Therapeutic Applications
•    Single Cell Analysis: Overcoming Challenges

View the Agenda https://bit.ly/2JLYhyf

The single cell analysis field is expanding. The costs of single cell technologies are reducing and this is allowing for more and more samples to be sequenced in parallel. Increased amounts of data have meant an influx of bioinformaticians and the kinds of tools needed to analyse single-cell data. With rare cell events potentially holding the answer to many issues in cancer, immunology, neurology and developmental biology, interest in the field has grown exponentially.

From the latest challenges in the field to exploring exciting developments in pre-implantation genetic diagnosis, multi-omic approaches, and spatially resolved single-cell sequencing data, this congress will be asking the pivotal question: “What is next in single cell analysis?”

Free Live Webinar for 2018

Revealing the Critical Regulators of Cell Identity in the Mouse Cell Atlas

Guo-Cheng Yuan, Associate Professor, Dana-Farber Cancer Institute
Thursday 6th September | 4pm BST

Can’t make the date? Register anyway and the recording will be sent to you afterwards.

Register Now https://bit.ly/2uwglCM

For further information regarding the conference programme, prices and possible discounts, please contact Angela Fernandez Saez on a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455.

As the drug discovery opportunity hidden within the proteome opens up and gains tremendous investment, the inaugural Targeted Protein Degradation Summit 2018 is a dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on this emerging therapeutic class.

Focus on understanding the selectivity and speed of binding, improve the rationale design of bifunctional molecules and overcome critical chemistry challenges to translate these unique small molecules into safe and effective clinical therapeutics.

Built with large pharma and biotech insight, the TPD 2018 is specifically focused on optimizing and accelerating the discovery, translational research and ultimately clinical development of targeted protein degradation therapies across all therapeutic indications.

Stay on the Pulse of Evolving Clinical Technology and Strategies to Enhance Clinical Trial Efficiencies

Utilizing mobile devices, sensors, wearable devices and other innovative technologies in clinical trial data collection may help provide more accurate clinical reporting by patients, minimize costs for sponsors and ultimately allow greater patient participation from remote locations, making trials more efficient. These benefits however come with challenges — from the design, implementation, execution and regulatory standpoint.

CBI’s eCOA/ePRO 2018 delivers strategies on how to leverage the latest innovations in eClinical technology as part of a clinical trial strategy. Don’t miss this opportunity for peer-to-peer benchmarking to gain actionable takeaways related to the use of technology to support clinical trials.

The reimbursement landscape for MedTech and medical devices is shifting and forcing manufacturers to innovate and rapidly adapt in order to ensure coverage for their products. CBI’S MedTech Reimbursement Summit delves into current reimbursement policies and practices, effective strategies for evidence generation and utilization and opportunities to develop cutting-edge coding mechanisms and cost-effectiveness and value demonstrations. As the paradigm shifts with the healthcare and pricing landscapes, hear about innovative opportunities to ensure reimbursement for MedTech products across public and private insurance.

Maximise the Impact of Precision Gene Editing to Drive Biomedical Applications & Future Breakthrough Therapies

With recent data questioning ‘precision’ editing, now is the time to ensure your CRISPR studies are fully optimised for greater specificity and efficiency with advanced verification protocols and off-target analysis. Discover how the best in the industry are developing innovative solutions to combat in vivo delivery challenges for biomedical research and therapeutic advancements to advance future breakthrough gene therapies.

With CRISPR officially cemented as THE editing tool transforming basic research and pharma R&D, the 3rd CRISPR Precision Genome Editing Europe 2018 is the meeting you cannot miss to keep up to date with vital developments in an industry that’s showing no signs of slowing down.

With less than 10 biosimilars approved by USFDA, the drug class is still in to infancy. However, market penetration rate is quite high with more biologic products going off patent. Amgen Inc.’s (AMGN) Amjevita, a biosimilar of AbbVie’s (ABBV) Humira (adalimumab) secured FDA approval in September 2016, but is yet to be marketed due to legal hurdles. Production bottlenecks are the second most obvious challenge since biosimilar manufacturing is complex, as the drugs are derived from living cells. This often leads to higher manufacturing costs and concerns about scalability potential of the manufactured biosimilars. Nevertheless, pricing is an important parameter requiring optimization. Pfizer Inc. (PFE) secured approval for Inflectra (infliximab-dyyb), its biosimilar of Johnson & Johnson’s (JNJ) Remicade, in April 2016. However, the price of Inflectra is only 15% lower than that of Remicade, and the much-anticipated launch dented the hopes of deep discounts from biosims. Generics usually cost 80% less than branded drugs.

With so many challenges in research, still class of drug is experiencing the maximum funding with great Returns on Investment (ROI).  Keeping these points in mind we are organizing the 13th International Conference on Biologics and Biosimilars during October 24-25, 2018 at Boston, USA with the theme: Emerging Trends in Biosimilars Approvals, Market and Pricing.